ABSI Valuation

Absci Corp

Add to Watchlist

Advanced Chart

2.690

+0.08(3.065%)1D

Overview
Forecast
Valuation
Earnings

ABSI Relative Valuation

ABSI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABSI is overvalued; if below, it's undervalued.

Historical Valuation

Absci Corp (ABSI) is now in the Fair zone, suggesting that its current forward PS ratio of 29.77 is considered Fairly compared with the five-year average of -5.66. The fair price of Absci Corp (ABSI) is between 0.27 to 6.28 according to relative valuation methord.

Relative Value

Fair Zone

0.27-6.28

Current Price：2.67

Fair

-3.68

Trailing

Forward

-2.52

EV/EBITDA

Absci Corp. (ABSI) has a current EV/EBITDA of -2.52. The 5-year average EV/EBITDA is -4.69. The thresholds are as follows: Strongly Undervalued below -19.25, Undervalued between -19.25 and -11.97, Fairly Valued between 2.58 and -11.97, Overvalued between 2.58 and 9.86, and Strongly Overvalued above 9.86. The current Forward EV/EBITDA of -2.52 falls within the Historic Trend Line -Fairly Valued range.

-2.34

EV/EBIT

Absci Corp. (ABSI) has a current EV/EBIT of -2.34. The 5-year average EV/EBIT is -3.94. The thresholds are as follows: Strongly Undervalued below -15.94, Undervalued between -15.94 and -9.94, Fairly Valued between 2.06 and -9.94, Overvalued between 2.06 and 8.06, and Strongly Overvalued above 8.06. The current Forward EV/EBIT of -2.34 falls within the Historic Trend Line -Fairly Valued range.

29.77

Absci Corp. (ABSI) has a current PS of 29.77. The 5-year average PS is 43.87. The thresholds are as follows: Strongly Undervalued below -40.10, Undervalued between -40.10 and 1.88, Fairly Valued between 85.85 and 1.88, Overvalued between 85.85 and 127.83, and Strongly Overvalued above 127.83. The current Forward PS of 29.77 falls within the Historic Trend Line -Fairly Valued range.

-4.45

P/OCF

Absci Corp. (ABSI) has a current P/OCF of -4.45. The 5-year average P/OCF is -7.18. The thresholds are as follows: Strongly Undervalued below -21.34, Undervalued between -21.34 and -14.26, Fairly Valued between -0.09 and -14.26, Overvalued between -0.09 and 6.99, and Strongly Overvalued above 6.99. The current Forward P/OCF of -4.45 falls within the Historic Trend Line -Fairly Valued range.

-4.14

P/FCF

Absci Corp. (ABSI) has a current P/FCF of -4.14. The 5-year average P/FCF is -5.38. The thresholds are as follows: Strongly Undervalued below -15.27, Undervalued between -15.27 and -10.33, Fairly Valued between -0.44 and -10.33, Overvalued between -0.44 and 4.51, and Strongly Overvalued above 4.51. The current Forward P/FCF of -4.14 falls within the Historic Trend Line -Fairly Valued range.

Absci Corp (ABSI) has a current Price-to-Book (P/B) ratio of 1.92. Compared to its 3-year average P/B ratio of 1.51 , the current P/B ratio is approximately 26.90% higher. Relative to its 5-year average P/B ratio of 1.35, the current P/B ratio is about 42.19% higher. Absci Corp (ABSI) has a Forward Free Cash Flow (FCF) yield of approximately -19.66%. Compared to its 3-year average FCF yield of -30.64%, the current FCF yield is approximately -35.84% lower. Relative to its 5-year average FCF yield of -26.77% , the current FCF yield is about -26.54% lower.

1.98

P/B

Median3y

1.51

Median5y

1.35

-19.66

FCF Yield

Median3y

-30.64

Median5y

-26.77

Competitors Valuation Multiple

The average P/S ratio for ABSI's competitors is 0.00, providing a benchmark for relative valuation. Absci Corp Corp (ABSI) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -53.31%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Monopar Therapeutics Inc

Loss

389.29M

GLUE.O

Monte Rosa Therapeutics Inc

Solid Biosciences Inc

Loss

400.75M

INBX.O

Inhibrx Biosciences Inc

Performance Decomposition

Market capitalization of ABSI decreased by 29.58% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -1.95K to -5.15K.

The secondary factor is the Revenue Growth, contributed -53.31%to the performance.

Overall, the performance of ABSI in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-53.31%

1.27M → 593.00K

Revenue Growth

164.52%

-1.95K → -5.15K

Margin Expansion

-140.79%

7.00 → -2.85

P/E Change

-29.58%